Literature DB >> 9971822

U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element.

L M McNally1, M T McNally.   

Abstract

Retroviruses require both spliced and unspliced RNA for replication. Accumulation of unspliced Rous sarcoma virus RNA is facilitated in part by a negative cis element in the gag region, termed the negative regulator of splicing (NRS), which serves to repress splicing of viral RNA but can also block splicing of heterologous introns. The NRS binds components of the splicing machinery including SR proteins, U1 and U2, small nuclear ribonucleoproteins (snRNPs) of the major splicing pathway, and U11 snRNP of the minor pathway, yet splicing does not normally occur from the NRS. A mutation that abolishes U11 binding (RG11) also abrogates NRS splicing inhibition, indicating that U11 is functionally important for NRS activity and suggesting that the NRS is recognized as a minor-class 5' splice site (5' ss). We show here, using specific NRS mutations to disrupt U11 binding and coexpression of U11 snRNA genes harboring compensatory mutations, that the NRS U11 site is functional when paired with a minor-class 3' ss from the human P120 gene. Surprisingly, the expectation that the same NRS mutants would be defective for splicing inhibition proved false; splicing inhibition was as good as, if not better than, that for the wild-type NRS. Comparison of these new mutations with RG11 indicated that the latter may disrupt binding of a factor(s) other than U11. Our data suggest that this factor is U1 snRNP and that a U1 binding site that overlaps the U11 site is also disrupted by RG11. Analysis of mutations which selectively disrupted U1 or U11 binding indicated that splicing inhibition by the NRS correlates most strongly with U1 snRNP. Additionally, we show that U1 binding is facilitated by SR proteins that bind to the 5' half of the NRS, confirming an earlier proposal that this region is involved in recruiting snRNPs to the NRS. These data indicate a functional role for U1 in NRS-mediated splicing inhibition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971822      PMCID: PMC104484     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing.

Authors:  M T McNally; R R Gontarek; K Beemon
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

Review 2.  Regulation of human immunodeficiency virus replication.

Authors:  B R Cullen
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

3.  Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing.

Authors:  S L Berberich; C M Stoltzfus
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging.

Authors:  C Méric; P F Spahr
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

5.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

Authors:  R A Katz; A M Skalka
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

6.  Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA.

Authors:  C M Stoltzfus; S J Fogarty
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 8.  Alternative splicing in the control of gene expression.

Authors:  C W Smith; J G Patton; B Nadal-Ginard
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

9.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.

Authors:  S Schwartz; B K Felber; D M Benko; E M Fenyö; G N Pavlakis
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

10.  Intronic sequences and 3' splice sites control Rous sarcoma virus RNA splicing.

Authors:  M T McNally; K Beemon
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

View more
  28 in total

1.  Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion.

Authors:  J Côté; S Dupuis; J Y Wu
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

2.  An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5' splice sites.

Authors:  A J McCullough; S M Berget
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Retroviral splicing suppressor requires three nonconsensus uridines in a 5' splice site-like sequence.

Authors:  R E Paca; C S Hibbert; C T O'Sullivan; K L Beemon
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  U1 snRNP-dependent function of TIAR in the regulation of alternative RNA processing of the human calcitonin/CGRP pre-mRNA.

Authors:  Hui Zhu; Robert A Hasman; Katherine M Young; Nancy L Kedersha; Hua Lou
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

5.  Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor.

Authors:  Javier Cabello-Villegas; Keith E Giles; Ana Maria Soto; Ping Yu; Annie Mougin; Karen L Beemon; Yun-Xing Wang
Journal:  RNA       Date:  2004-09       Impact factor: 4.942

6.  Retroviral splicing suppressor sequesters a 3' splice site in a 50S aberrant splicing complex.

Authors:  Keith E Giles; Karen L Beemon
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation.

Authors:  Jeremy E Wilusz; Karen L Beemon
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

8.  Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.

Authors:  Nicole L Maciolek; Mark T McNally
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

9.  Efficient polyadenylation of Rous sarcoma virus RNA requires the negative regulator of splicing element.

Authors:  Brent L Fogel; Lisa M McNally; Mark T McNally
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

10.  Interaction between the negative regulator of splicing element and a 3' splice site: requirement for U1 small nuclear ribonucleoprotein and the 3' splice site branch point/pyrimidine tract.

Authors:  C R Cook; M T McNally
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.